SchalkLouw

BRICS currencies movement for the week – 10 July 2020

FX:USDZAR   U.S. Dollar / South African Rand
This has been the third week in a row where the Rand (ZAR) outperformed both the USD and all other BRIC currencies. Over the shorter-term period, while commodity prices (Gold, Platinum, Palladium, etc) are running, I would not be shorting the ZAR now, as this is still very good for the South African economy.

BRICS currency/USD movements for this week:

Brazil -0.1%
Russia +0.7%
India -0.7%
China +0.9%
South Africa +1.5%

Euro /USD +0.4%

Technically, the ZAR remained within the parallel channel, with the top resistance level again being seriously tested on both Tuesday and Wednesday. We again saw the 21-day Moving Average (EMA) acting as a very strong resistance level.

I will still be monitoring the R16.85/USD level in the early part of this coming week. A break and close above the parallel channel could see the ZAR seeking resistance at the 21-day EMA at R17.09, with a break and close above these levels, seeking resistance at the 5-day EMA (R17.29). Should we break above R17.30, the next target becomes R17.65.

Should we however stay below R16.85 and below the 8-day EMA at R16.95, we could see the ZAR moving closer to the strong support level (bottom of the parallel channel) at R16.50 again. A break a close below this level could see the ZAR back testing the 200-day EMA (R16.41), with a break and close below, very much putting us back at my medium-term target, R15.50.

Al three the 8-, 21- and 50-day EMA are still pointing downward, which is a good indication that the trend is still looking a lot healthier.

I will however still caution any short positions prior to a confirmation-break below R16.50 and remain Neutral for now. For those traders considering a long USDZAR (short ZAR) position, should wait for a proper break and close above R17.30. The most likely trading band this week is being between R16.40 and R17.10.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.